| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
|
N Engl J Med
|
2003
|
15.48
|
|
2
|
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
|
J Infect Dis
|
2010
|
8.37
|
|
3
|
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
|
N Engl J Med
|
2006
|
7.68
|
|
4
|
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.
|
Lancet
|
2006
|
5.56
|
|
5
|
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
|
JAMA
|
2005
|
5.29
|
|
6
|
Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
|
J Infect Dis
|
2008
|
4.91
|
|
7
|
Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.
|
N Engl J Med
|
2009
|
4.38
|
|
8
|
Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States.
|
Nat Med
|
2003
|
3.54
|
|
9
|
Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.
|
JAMA
|
2004
|
3.05
|
|
10
|
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).
|
MMWR Morb Mortal Wkly Rep
|
2014
|
3.05
|
|
11
|
Bacterial meningitis in the United States, 1998-2007.
|
N Engl J Med
|
2011
|
2.99
|
|
12
|
Medical education for a healthier population: reflections on the Flexner Report from a public health perspective.
|
Acad Med
|
2010
|
1.80
|
|
13
|
Physician practices and attitudes regarding adult immunizations.
|
Prev Med
|
2005
|
1.62
|
|
14
|
Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008.
|
J Pediatr
|
2010
|
1.47
|
|
15
|
Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009.
|
Clin Infect Dis
|
2014
|
1.47
|
|
16
|
Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.
|
J Infect Dis
|
2011
|
1.42
|
|
17
|
Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003-2008.
|
Pediatr Infect Dis J
|
2010
|
1.41
|
|
18
|
Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States.
|
J Infect Dis
|
2010
|
1.40
|
|
19
|
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.
|
J Infect Dis
|
2011
|
1.33
|
|
20
|
Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults.
|
Am J Public Health
|
2010
|
1.33
|
|
21
|
Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.
|
Pediatrics
|
2010
|
1.26
|
|
22
|
Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children.
|
Clin Infect Dis
|
2012
|
1.26
|
|
23
|
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
|
MMWR Morb Mortal Wkly Rep
|
2015
|
1.21
|
|
24
|
Developing an interdisciplinary, community-based education program for health professions students: the Rochester experience.
|
Acad Med
|
2006
|
1.16
|
|
25
|
Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.
|
Clin Infect Dis
|
2011
|
1.15
|
|
26
|
Community needs, concerns, and perceptions about health research: findings from the clinical and translational science award sentinel network.
|
Am J Public Health
|
2013
|
1.12
|
|
27
|
Human papillomavirus genotypes in high-grade cervical lesions in the United States.
|
J Infect Dis
|
2012
|
1.12
|
|
28
|
Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010.
|
J Infect Dis
|
2013
|
1.11
|
|
29
|
Increase in rates of hospitalization due to laboratory-confirmed influenza among children and adults during the 2009-10 influenza pandemic.
|
J Infect Dis
|
2012
|
1.06
|
|
30
|
Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions.
|
Vaccine
|
2012
|
1.03
|
|
31
|
Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic.
|
Clin Infect Dis
|
2012
|
1.02
|
|
32
|
Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003.
|
Clin Infect Dis
|
2006
|
1.02
|
|
33
|
Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases.
|
Am J Obstet Gynecol
|
2011
|
0.99
|
|
34
|
Increasing inner-city adult influenza vaccination rates: a randomized controlled trial.
|
Public Health Rep
|
2011
|
0.98
|
|
35
|
Influenza vaccine supply and racial/ethnic disparities in vaccination among the elderly.
|
Am J Prev Med
|
2011
|
0.92
|
|
36
|
Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period.
|
Vaccine
|
2012
|
0.92
|
|
37
|
The burden of influenza hospitalizations in infants from 2003 to 2012, United States.
|
Pediatr Infect Dis J
|
2014
|
0.91
|
|
38
|
The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions.
|
Cancer Causes Control
|
2011
|
0.89
|
|
39
|
An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States.
|
PLoS One
|
2012
|
0.89
|
|
40
|
Estimating medical practice expenses from administering adult influenza vaccinations.
|
Vaccine
|
2005
|
0.88
|
|
41
|
Influenza-associated hospitalizations by industry, 2009-10 influenza season, United States.
|
Emerg Infect Dis
|
2012
|
0.86
|
|
42
|
Evaluating community engagement in an academic medical center.
|
Acad Med
|
2014
|
0.85
|
|
43
|
Risk factors for cartilage infections of the ear.
|
Am J Prev Med
|
2005
|
0.84
|
|
44
|
Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003.
|
Emerg Infect Dis
|
2007
|
0.84
|
|
45
|
Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.
|
Emerg Infect Dis
|
2015
|
0.83
|
|
46
|
Effects of an ongoing epidemic on the annual influenza vaccination rate and vaccination timing among the Medicare elderly: 2000-2005.
|
Am J Public Health
|
2009
|
0.82
|
|
47
|
Nomenclature in translational research.
|
JAMA
|
2008
|
0.81
|
|
48
|
Twenty Years of Active Bacterial Core Surveillance.
|
Emerg Infect Dis
|
2015
|
0.81
|
|
49
|
Adults with invasive pneumococcal disease: missed opportunities for vaccination.
|
Am J Prev Med
|
2006
|
0.80
|
|
50
|
Training in Infectious Disease Epidemiology through the Emerging Infections Program Sites.
|
Emerg Infect Dis
|
2015
|
0.79
|
|
51
|
Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates.
|
Emerg Infect Dis
|
2015
|
0.79
|
|
52
|
Emerging Infections Program Efforts to Address Health Equity.
|
Emerg Infect Dis
|
2015
|
0.79
|
|
53
|
Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of age: an emerging infections program study.
|
Pediatr Infect Dis J
|
2014
|
0.77
|
|
54
|
Why do not patients receive influenza vaccine in December and January?
|
Vaccine
|
2005
|
0.75
|
|
55
|
Mass vaccination clinics versus appointments.
|
J Med Pract Manage
|
2006
|
0.75
|
|
56
|
Operational conditions affecting the vaccination of older adults.
|
Am J Prev Med
|
2004
|
0.75
|